BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7803282)

  • 1. Distinct lysozyme content in different subtypes of acute myeloid leukaemic cells: an ultrastructural immunogold study.
    Resnitzky P; Shaft D
    Br J Haematol; 1994 Oct; 88(2):357-63. PubMed ID: 7803282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct intracellular lysozyme content in normal granulocytes and monocytes: a quantitative immunoperoxidase and ultrastructural immunogold study.
    Resnitzky P; Shaft D; Yaari A; Nir E
    J Histochem Cytochem; 1994 Nov; 42(11):1471-7. PubMed ID: 7930529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
    da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
    Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness and limitations of serum and urine lysozyme levels in the classification of acute myeloid leukemia: an analysis of 208 cases.
    Sexton C; Buss D; Powell B; O'Connor M; Rainer R; Woodruff R; Cruz J; Pettenati M; Rao PN; Case LD
    Leuk Res; 1996 Jun; 20(6):467-72. PubMed ID: 8709618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural characteristics and lysozyme content in hypergranular and variant type of acute promyelocytic leukaemia.
    Shaft D; Shtalrid M; Berebi A; Catovsky D; Resnitzky P
    Br J Haematol; 1998 Dec; 103(3):729-39. PubMed ID: 9858224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
    Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells.
    Dengler R; Münstermann U; al-Batran S; Hausner I; Faderl S; Nerl C; Emmerich B
    Br J Haematol; 1995 Feb; 89(2):250-7. PubMed ID: 7873374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic application of monoclonal antibody KB90 (CD11c) in acute myeloid leukaemia.
    Master PS; Richards SJ; Kendall J; Roberts BE; Scott CS
    Blut; 1989 Sep; 59(3):221-5. PubMed ID: 2477088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase-deficient polymorphonuclear leucocytes. (IV): Relation to FAB-classification in acute myeloid leukaemia.
    Bendix-Hansen K; Nielsen HK
    Scand J Haematol; 1985 Aug; 35(2):174-7. PubMed ID: 2996122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural localization of lysozyme in human neutrophils by immunogold.
    Cramer EM; Breton-Gorius J
    J Leukoc Biol; 1987 Mar; 41(3):242-7. PubMed ID: 3470418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies.
    Li WV; Kapadia SB; Sonmez-Alpan E; Swerdlow SH
    Mod Pathol; 1996 Oct; 9(10):982-8. PubMed ID: 8902835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of acute myeloid leukaemia in trephine biopsies with special reference to lactoferrin.
    Al Safadi L; Köhler G; Schaefer HE
    Anticancer Res; 1998; 18(5B):3677-84. PubMed ID: 9854476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia.
    Okada S; Hongo T; Yamada S; Watanabe C; Fujii Y; Ohzeki T; Horikoshi Y; Ito T; Yazaki M; Komada Y; Tawa A
    Br J Haematol; 2003 Dec; 123(5):802-9. PubMed ID: 14632770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic significance of serum measurements of lactoferrin, lysozyme and myeloperoxidase in acute myeloid leukemia (AML): recognition of a new variant, high-lactoferrin AML.
    Oberg G; Dahl R; Ellegaard J; Sundström C; Vaeth M; Venge P
    Eur J Haematol; 1987 Feb; 38(2):148-55. PubMed ID: 3036571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation.
    Vinante F; Rigo A; Tecchio C; Patuzzo C; Ricetti MM; Morosato L; Cassatella MA; Chilosi M; Pizzolo G
    Haematologica; 1996; 81(3):195-200. PubMed ID: 8767523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activation in human acute leukaemias.
    Scherrer A; Wohlwend A; Kruithof EK; Vassalli JD; Sappino AP
    Br J Haematol; 1999 Jun; 105(4):920-7. PubMed ID: 10554801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative enzyme determination in acute myeloid leukemia.
    Ossenkoppele GJ; Wijermans PJ; Huijgens PC; Nauta JJ; Langenhuijsen MM
    Leuk Res; 1991; 15(6):481-6. PubMed ID: 1650411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrastructural localization of peroxidases in myeloid cells].
    Foa R; Foa C; Muratore R; Olmer J
    C R Seances Soc Biol Fil; 1970; 164(3):591-3. PubMed ID: 4250416
    [No Abstract]   [Full Text] [Related]  

  • 20. Ultrastructural cytochemistry of leukaemic cells: characterization of the early small granules of monoblasts.
    O'Brien M; Catovsky D; Costello C
    Br J Haematol; 1980 Jun; 45(2):201-8. PubMed ID: 6254558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.